ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 80 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q1 2022. The put-call ratio across all filers is 4.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,551,263 | +18.3% | 10,963,158 | +40.3% | 0.31% | -7.0% |
| Q2 2023 | $7,226,588 | +22.0% | 7,812,528 | +43.7% | 0.33% | -1.8% |
| Q1 2023 | $5,924,629 | -23.2% | 5,435,439 | +2.9% | 0.34% | -37.0% |
| Q4 2022 | $7,714,113 | +49.8% | 5,283,639 | +10.3% | 0.53% | +6.0% |
| Q3 2022 | $5,149,000 | -35.3% | 4,789,490 | +2.4% | 0.50% | -39.8% |
| Q2 2022 | $7,955,000 | -12.8% | 4,679,491 | +5.6% | 0.83% | -28.9% |
| Q1 2022 | $9,125,000 | +12.5% | 4,429,491 | +104.8% | 1.17% | +9.2% |
| Q4 2021 | $8,109,000 | – | 2,162,313 | – | 1.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 1,377,294 | $1,501,250 | 2.44% |
| NEA Management Company, LLC | 17,079,779 | $18,616,958 | 1.29% |
| Endurant Capital Management LP | 1,660,835 | $1,810,310 | 0.93% |
| Matrix Capital Management Company, LP | 38,974,185 | $42,481,862 | 0.58% |
| Long Focus Capital Management, LLC | 5,435,439 | $5,924,629 | 0.34% |
| PFM Health Sciences, LP | 5,992,571 | $6,531,902 | 0.29% |
| Key Client Fiduciary Advisors, LLC | 321,155 | $350,059 | 0.22% |
| DAFNA Capital Management LLC | 351,064 | $382,660 | 0.12% |
| Rock Springs Capital Management LP | 2,787,845 | $3,038,751 | 0.07% |
| Baker Brothers Advisors | 9,830,877 | $10,715,656 | 0.06% |